Proteomic analysis of peripheral blood mononuclear cells isolated from patients with pulmonary tuberculosis: A pilot study from Zanzibar, Tanzania
PLOS ONE · 14.02.2023 · 18 (2) · e0281757
DOI: 10.1371/journal.pone.0281757 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 14.02.2023. Verfasst von Ahmed Barakat und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges Forskningsråd.
Abstract (Originalsprache)
This study aimed at exploring the proteomic profile of PBMCs to predict treatment response in pulmonary tuberculosis (PTB). This was a pilot study conducted among 8 adult patients from Zanzibar, Tanzania with confirmed PTB. Blood samples were collected at baseline, at 2 months of treatment, and at the end of treatment at 6 months. Proteins were extracted from PBMCs and analyzed using LC-MS/MS based label free quantitative proteomics. Overall, 3,530 proteins were quantified across the samples, and 12 differentially expressed proteins were identified at both 2 months of treatment and at treatment completion, which were involved in cellular and metabolic processes, as well as binding and catalytic activity. Seven were downregulated proteins (HSPA1B/HSPA1A, HSPH1, HSP90AA1, lipopolysaccharide-binding protein, complement component 9, calcyclin-binding protein, and protein transport protein Sec31A), and 5 proteins were upregulated (SEC14 domain and spectrin repeat-containing protein 1, leucine-rich repeat-containing 8 VRAC subunit D, homogentisate 1,2-dioxygenase, NEDD8-activating enzyme E1 regulatory subunit, and N-acetylserotonin O-methyltransferase-like protein). The results showed that proteome analysis of PBMCs can be used as a novel technique to identify protein abundance change with anti-tuberculosis treatment. The novel proteins elucidated in this work may provide new insights for understanding PTB pathogenesis, treatment, and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
- Proteomics Unit at University of Bergen (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.
- Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
- Department of Medical Affairs, Partner 4 Health, Paris, France.
- Department of Diagnostic Services, Mnazi Mmoja Hospital, Zanzibar, The United Republic of Tanzania.
ORCID-Profile: Tehmina Mustafa
Förderung
- Norges Forskningsråd
Zitieren
APA
Barakat, A., Birkeland, E., Jørstad, M. D., El Hajj, M., Marijani, M., Døskeland, A., Mjaavatten, O., Berven, F. S., & Mustafa, T. (2023). Proteomic analysis of peripheral blood mononuclear cells isolated from patients with pulmonary tuberculosis: A pilot study from Zanzibar, Tanzania. PLOS ONE, 18(2), e0281757. https://doi.org/10.1371/journal.pone.0281757
Vancouver
Barakat A, Birkeland E, Jørstad MD, El Hajj M, Marijani M, Døskeland A, et al. Proteomic analysis of peripheral blood mononuclear cells isolated from patients with pulmonary tuberculosis: A pilot study from Zanzibar, Tanzania. PLOS ONE. 2023;18(2):e0281757. doi:10.1371/journal.pone.0281757
BibTeX
@article{Barakat2023,
author = {Barakat, Ahmed and Birkeland, Even and Jørstad, Melissa D and El Hajj, Magalie and Marijani, Msafiri and Døskeland, Anne and Mjaavatten, Olav and Berven, Frode S and Mustafa, Tehmina},
title = {Proteomic analysis of peripheral blood mononuclear cells isolated from patients with pulmonary tuberculosis: A pilot study from Zanzibar, Tanzania},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {2},
pages = {e0281757},
doi = {10.1371/journal.pone.0281757}
}
EUVIMED